Washington — The United States has announced a major review and update of its childhood immunization schedule, marking a significant shift in federal public health policy intended to align recommendations with practices in other developed countries and to respond to changing views on vaccination guidance.
The action follows a Presidential Memorandum signed last December directing the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) to compare the U.S. routine childhood vaccine schedule with those of peer nations, including Denmark, Japan and Germany, which routinely recommend fewer immunizations. Officials said the review is part of a broader effort to ensure that U.S. vaccination guidance reflects best practices while maintaining access to vaccines currently available to American families. The White House+1
Under the revised framework, the CDC is reshaping how certain vaccines are recommended. While core immunizations such as those for measles, mumps and polio will continue to be broadly advised for all children, a number of vaccines previously on the universal schedule — including those for influenza, rotavirus, and hepatitis A — will now be recommended only for children in high-risk groups or based on individual consultation between parents and health care providers. Federal officials described this “shared clinical decision-making” model as offering greater flexibility and transparency for families making health choices for their children. Reuters
Health Secretary Robert F. Kennedy Jr. said the move was informed by international comparisons and designed to “protect children, respect families and rebuild trust in public health,” a message echoed by senior HHS officials. They stressed that all vaccines will remain accessible to those who choose them, and that insurance coverage through private plans, Medicare, Medicaid and the Children’s Health Insurance Program will continue uninterrupted. The Washington Post
Public health experts, however, voiced concerns about the approach and the process behind it. Some medical organizations have publicly questioned the decision to adjust recommendations without a more extensive scientific review and open discussion, particularly pointing to the potential for misunderstanding or reduced uptake of vaccinations that have historically prevented serious childhood illnesses. Critics also noted that comparisons with peer countries do not always account for differences in population size, health systems, and disease risk patterns. The Washington Post
A notable example prompting debate involved the federal advisory panel’s vote earlier this winter to change guidance on hepatitis B vaccination at birth, a recommendation that previously helped reduce the incidence of the virus among newborns in the U.S. The panel’s decision to limit the universal recommendation raised questions about how such shifts might affect long-term immunity and surveillance of preventable diseases. TIME
CDC and HHS officials said they expect the updated schedule and its rationale to be published publicly in the coming weeks, with guidance materials available on CDC’s official website. They also underscored that decisions are based on evolving evidence and aim to support parents and health care professionals in making informed decisions tailored to individual health needs.
